Skip to main content
Part of Sickle Cell Disease on Somebody To Talk To
Loading page…
Bioverativ and Sangamo announce FDA acceptance of IND application for gene-edited cell therapy BIVV003 to treat sickle cell disease (2018 archive) | oneSCDvoice